CareLit · DOI-Nachweis · Osteologie
A single infusion of Zoledronic Acid after terminating treatment with Denosumab prevents rebound-fractures and rapid loss of bone mineral densitiy in most, but not all patients treated for Osteoporosis
DOI 10.1055/s-0039-1679969
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Lehmann, J Everts
ZeitschriftOsteologie
Ausgabe01/2019
Jahrgang / SeitenJg. 28
Kernaussage aus der Literatur
Abstract-Vorschau
A single infusion of Zoledronic Acid after terminating treatment with Denosumab prevents rebound-fractures and rapid loss of bone mineral densitiy in most, but not all patients treated for Osteoporosis
Zitieren
Zitierempfehlung
T Lehmann, J Everts (2019) A single infusion of Zoledronic Acid after terminating treatment with Denosumab prevents rebound-fractures and rapid loss of bone mineral densitiy in most, but not all patients treated for Osteoporosis. Osteologie, 28 (01). https://doi.org/10.1055/s-0039-1679969
Mit CareLit weiterarbeiten